Evidence map›Paper›PMID 32817576›Full record

ArticlePostgraduate medical journal2021

Risk-benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19.

Sivaraman Dhanasekaran, Leela Kagithakara Vajravelu, Venugopal Venkatesalu

Full text readLetter
In one paragraph

Article in Postgraduate medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sivaraman DhanasekaranDepartment of Pharmacology and Toxicology, Centre for Laboratory Animal Technology and Research, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India sivaramand83@gmail.com sivaraman.clatr@sathyabama.ac.in.ORCID 0000-0002-6889-2434
Leela Kagithakara VajraveluDepartment of Microbiology, SRM Medical College Hospital and Research Centre, Kancheepuram, Tamil Nadu, India.
Venugopal VenkatesaluDepartment of Internal Medicine, Sundaram Health Centre, Sholinghur, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 SerotherapyHumansImmunization, PassiveRisk AssessmentTreatment Outcomeinfection controlInfectious diseasestherapeutics

Identifiers

PMID32817576
PMCPMC10016903

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.